This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Georgetown University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Louis Weiner
Introduction
Louis Weiner is a prominent inventor based in Washington, DC, known for his significant contributions to cancer treatment. He has developed a unique method for treating cancerous tumors that express cholecystokinin (CCK) receptors. His innovative approach combines the use of a CCK receptor inhibitor with an immune checkpoint inhibitor, showcasing his commitment to advancing medical science.
Latest Patents
Weiner holds 1 patent for his groundbreaking work titled "Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor." This patent outlines methods for effectively treating tumors by administering a CCK receptor inhibitor alongside an immune checkpoint inhibitor. The CCK receptor inhibitor targets specific receptors, including CCK-A, CCK-B, and CCK-C, while the immune checkpoint inhibitor focuses on programmed cell death protein 1 (PD1) or cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4).
Career Highlights
Louis Weiner has made significant strides in the field of oncology through his research and inventions. His work at Georgetown University has positioned him as a leader in cancer treatment innovation. He continues to explore new methodologies that enhance the effectiveness of cancer therapies.
Collaborations
Weiner collaborates with esteemed colleagues, including Jill P Smith and Sandeep Nadella, to further his research and development efforts. These partnerships enhance the potential impact of his work in the medical community.
Conclusion
Louis Weiner's innovative approach to cancer treatment exemplifies the power of combining different therapeutic strategies. His contributions are paving the way for more effective cancer therapies, ultimately benefiting patients worldwide.